廣濟藥業(000952.SZ):全資子公司完成工商登記並取得營業執照
格隆匯6月4日丨廣濟藥業(000952.SZ)公佈,近日,公司全資子公司已完成工商登記並取得武穴市市場監督管理局發放的營業執照,具體登記信息如下:
1、名稱:湖北濟得藥業有限公司
2、統一社會信用代碼:91421182MA49GEYX4R
3、類型:有限責任公司(非自然人投資或控股的法人獨資)
4、住所:湖北省黃岡市武穴市武穴江堤路1號
5、法定代表人:安靖
6、註冊資本:貳仟萬圓整
7、成立日期:2020年06月01日
8、營業期限:長期
9、經營範圍:生產經營注射劑、原料藥;保健品、生物製品、醫療器械、消毒產品、食品添加劑、飼料添加劑的生產、銷售(不含危險化學品);生產直接接觸藥品內裝材料;單一飼料的生產、銷售;產品研發、關聯項目的生產經營合作。(涉及許可經營項目,應取得相關部門許可後方可經營)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.